Abstract
Aminoglycoside prescriptions were rarely evaluated in children care facilities. Because of risk of toxicity, these narrow spectrum antibiotics are commonly misused. In this study, we evaluate aminoglycoside prescription and assess the impact of an information campaign on modalities of prescription and monitoring practices in a pediatric hospital. This prospective study, before/after diffusion of local recommendations, has been conducted over 6 months. All computerized prescriptions were analyzed. A semi-passive diffusion of local recommendations to prescribers allowed researchers to differentiate between a pre-intervention (P1) and post-intervention period (P2). Endpoints were the improvement of administered doses (mg/kg), modalities of administration, treatment duration, indications, and the presence of pharmacological monitoring. Three hundred and ten prescriptions were analyzed (P1 = 163, P2 = 147). Most common sites of infection treated were as follows: joint-bone (33 %), urinary tract (17 %) and intra-abdominal (15 %). Among all prescriptions, respectively, 12 and 13 % were avoidable. Short-duration treatment and single daily dosing seem to be widely achieved, but despite an improvement between the two periods, 45 % of pre...Continue Reading
References
Jan 1, 1987·The Journal of Infectious Diseases·R D MooreC R Smith
Mar 1, 1993·Diagnostic Microbiology and Infectious Disease·J J SchentagM H Adelman
Aug 1, 1996·Journal of Clinical Pharmacy and Therapeutics·S Braybrook, R Walker
Jan 22, 1998·The New England Journal of Medicine·R S EvansJ P Burke
Jun 5, 1998·Family Practice·C W Onion, C A Bartzokas
Oct 26, 1999·The Annals of Pharmacotherapy·R S EvansJ P Burke
Oct 27, 1999·JAMA : the Journal of the American Medical Association·M D CabanaH R Rubin
Jul 18, 2000·Antimicrobial Agents and Chemotherapy·H DupontJ Carlet
Aug 30, 2001·Archives of Internal Medicine·D H SolomonJ Avorn
Aug 4, 2004·The Lancet Infectious Diseases·Nasia SafdarDennis G Maki
Oct 15, 2005·Clinical Microbiology Reviews·Conan MacDougall, Ron E Polk
Jan 18, 2006·Internal Medicine Journal·C L LeongA Street
Jan 27, 2006·The Cochrane Database of Systematic Reviews·M PaulL Leibovici
Feb 28, 2006·The Journal of Antimicrobial Chemotherapy·Matthew E FalagasIoannis A Bliziotis
Jun 1, 2006·The American Journal of Medicine·Neil Fishman
Jul 27, 2006·The Journal of Antimicrobial Chemotherapy·Jean-Ralph ZaharPhilippe Lesprit
Oct 13, 2007·Proteins·Nicholas O'Toole, Ilya A Vakser
Jun 10, 2008·American Journal of Infection Control·Teresa C HoranMargaret A Dudeck
Mar 7, 2009·The Journal of Antimicrobial Chemotherapy·Philippe LespritChristian Brun-Buisson
Dec 26, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Joseph S SolomkinJohn G Bartlett
Apr 8, 2010·Critical Care : the Official Journal of the Critical Care Forum·Fabio Silvio TacconeFrédérique Jacobs
Jun 30, 2010·Antimicrobial Agents and Chemotherapy·J A MartínezJ Mensa
Sep 20, 2011·Critical Care Medicine·Matthieu LegrandElie Azoulay
Dec 14, 2011·Annales Françaises D'anesthèsie Et De Rèanimation·M-O FischerJ-L Fellahi
Aug 8, 2013·JAMA Pediatrics·Pranita D TammaSara E Cosgrove
Citations
Jan 11, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J RobertUNKNOWN Société de Pathologie Infectieuse de Langue Française (SPILF), the Observatoire National de l’Epidémiologie de la Résistance
Jun 12, 2020·Infection·Max SchelerArne Simon
Feb 19, 2021·Klinische Pädiatrie·Sarah HerbergerArne Simon
Aug 17, 2021·Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie·S ManenG Mortamet